Annika Kers

This inventor holds 17 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Astrazeneca Ab, Acturum Real Estate Ab, Arcturum Real Estate Ab. Active years: 2008-2026.

USPTO Granted Patents = 17 (Patent Applications = 4)

% Patents Active = 58.8

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 5 (Patent Applications = 6)

Average Co-Inventor Count = 9.8

ph-index = 4

Forward Citations = 63(Granted Patents)

Location History:

Sodertalje, SE (2008 - 2012)
Södertälje, SE (2009 - 2013)
Macclesfield, GB (2014 - 2019)
Stockholm, SE (2018 - 2019)
Malmö, SE (2017 - 2020)

Company Filing History:

Acturum Real Estate Ab

patent

1 out of 1

Arcturum Real Estate Ab

patent

4. 1 out of 126

Astex Therapeutics Limited

patents

where one patent can have more than one assignee

Years Active: 2008-2026

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12516023 - NMDA antagonist prodrugs (2026-01-06),

2. 10815199 - NMDA antagonist prodrugs (2020-10-27),

3. 10231967 - Compounds and their use as BACE inhibitors (2019-03-19),

4. 10227296 - Bis(sulfonamide) derivatives and their use as mPGES inhibitors (2019-03-12),

5. 10207994 - NMDA antagonist prodrugs (2019-02-19),

6. 10081614 - Bis(sulfonamide) derivatives and their use as mPGES inhibitors (2018-09-25),

7. 9918985 - Compounds and their use as BACE inhibitors (2018-03-20),

8. 9822075 - NMDA antagonist prodrugs (2017-11-21),

9. 9248129 - Compounds and their use as BACE inhibitors (2016-02-02),

10. 8865911 - Compounds and their use as BACE inhibitors (2014-10-21),

11. 8415483 - Compounds and their use as BACE inhibitors (2013-04-09),

12. 8158785 - 5,7-disubstituted[1.3]thiazolo [4,5-D] pyrimidin-2(3H)-amine derivatives and their use in therapy (2012-04-17),

13. 7960395 - 5,7-disubstituted thiazolo[4,5-d]pyrimidines for the selective inhibition of chemokine receptors (2011-06-14),

14. 7855213 - Compounds (2010-12-21),

15. 7585881 - Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists (2009-09-08),

Title: The Innovative Journey of Annika Kers

Introduction: Annika Kers is a pioneering inventor hailing from Södertälje, Sweden, known for her groundbreaking contributions to the field of technology and innovation.

Latest Patents: Annika Kers has recently been granted patents for her cutting-edge inventions in the areas of renewable energy solutions and sustainable transportation methods.

Career Highlights: With a career spanning over two decades, Annika Kers has established herself as a leading figure in the world of innovation, with a particular focus on eco-friendly technologies and smart city initiatives.

Collaborations: Throughout her career, Annika Kers has collaborated with top research institutions, universities, and forward-thinking companies to bring her visionary ideas to life and make a positive impact on the world.

Conclusion: Annika Kers continues to inspire the next generation of inventors with her passion for creating a more sustainable and technologically advanced future.